Tenet (THC) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $6.12
- EPS estimate
- $4.26
- EPS surprise
- +43.63%
- Revenue surprise
- +3.62%
- Revenue
- $5.6B
- Revenue estimate
- $5.4B
- Reported
- Jul 23, 2026
Tenet Healthcare reported Q2 2026 results on July 23, 2026. Earnings per share were $6.12, ahead of the $4.26 estimate by 43.63%. Revenue of $5.6 billion beat the $5.4 billion consensus by 3.62%. Compared with Q2 2025, EPS rose about 52% from $4.02, and revenue rose from $5.3 billion. Both figures are the highest in the table.
The longer record shows fast earnings growth on steady sales. Annual EPS was $6.83 in 2022 and $6.98 in 2023, then rose to $11.90 in 2024 and $16.78 in 2025. Quarterly revenue stayed in a narrow range, between $4.6 billion and $5.6 billion. The first half of 2026 adds up to $10.94 per share, about 31% more than the $8.38 a year earlier. Tenet topped the EPS estimate in all 20 quarters in the table, often by wide margins. The largest beats were Q2 2022, at 123.71%, and Q1 2024, at 121.66%.
Tenet reported Q3 between October 20 and October 30 in each of the past five years. That points to late October 2026 for the next report. It will show whether the year-over-year growth seen in the first half continues.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 23, 2026 | $4.26 | $6.12 | +43.63% | $5.6B | SEC |
| Q1 2026 | Apr 30, 2026 | $4.17 | $4.82 | +15.72% | $5.4B | SEC |
| Q4 2025 | Feb 11, 2026 | $4.09 | $4.70 | +14.83% | $5.5B | SEC |
| Q3 2025 | Oct 28, 2025 | $3.34 | $3.70 | +10.88% | $5.3B | SEC |
| Q2 2025 | Jul 22, 2025 | $2.87 | $4.02 | +39.85% | $5.3B | SEC |
| Q1 2025 | Apr 29, 2025 | $3.12 | $4.36 | +39.58% | $5.2B | SEC |
| Q4 2024 | Feb 12, 2025 | $2.95 | $3.44 | +16.53% | $5.1B | SEC |
| Q3 2024 | Oct 29, 2024 | $2.37 | $2.93 | +23.88% | $5.1B | SEC |
| Q2 2024 | Jul 24, 2024 | $1.91 | $2.31 | +21.08% | $5.1B | SEC |
| Q1 2024 | Apr 30, 2024 | $1.45 | $3.22 | +121.66% | $5.4B | SEC |
| Q4 2023 | Feb 8, 2024 | $1.60 | $2.68 | +67.31% | $5.4B | SEC |
| Q3 2023 | Oct 30, 2023 | $1.20 | $1.44 | +20.41% | $5.1B | SEC |
| Q2 2023 | Jul 31, 2023 | $1.25 | $1.44 | +15.34% | $5.1B | SEC |
| Q1 2023 | Apr 25, 2023 | $1.16 | $1.42 | +22.90% | $5.0B | SEC |
| Q4 2022 | Feb 9, 2023 | $1.23 | $1.96 | +59.56% | $5.0B | SEC |
| Q3 2022 | Oct 20, 2022 | $1.24 | $1.44 | +15.87% | $4.8B | SEC |
| Q2 2022 | Jul 21, 2022 | $0.67 | $1.50 | +123.71% | $4.6B | SEC |
| Q1 2022 | Apr 20, 2022 | $1.08 | $1.93 | +79.45% | $4.7B | SEC |
| Q4 2021 | Feb 7, 2022 | $1.52 | $2.70 | +77.81% | $4.9B | SEC |
| Q3 2021 | Oct 20, 2021 | $1.03 | $1.99 | +93.73% | $4.9B | SEC |
Quarterly revenue
Frequently asked questions
When did Tenet (THC) last report earnings?
Tenet last reported on Jul 23, 2026, covering fiscal Q2 2026.
Did THC beat earnings estimates?
Yes. Tenet reported EPS of $6.12 for Q2 2026 against a $4.26 estimate — a 43.63% beat.
How much revenue did THC report last quarter?
Tenet reported $5.6B in revenue for Q2 2026, against a consensus estimate of $5.4B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.